 Pro-inflammatory cytokines play a pivotal role in osteoarthritis, as well as in bone tunnel widening after ACL reconstructive surgery. A new treatment option is to administer autologous conditioned serum ACS containing endogenous anti-inflammatory cytokines including IL-1Ra and growth factors IGF-1, PDGF and TGF-ß1, among others in the liquid blood phase. 